TECP
IMA

Trails Edge Capital Partners’s ImageneBio Inc IMA Stock Holding History

Trails Edge Capital Partners’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
+282,004
New +$1.59M 0.26% 35

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Trails Edge Capital Partners's IMA Position: Q2 2026 in Review

Trails Edge Capital Partners opened a new position in ImageneBio Inc (IMA) in Q2 2026: 282,004 shares worth $1.66M. The stake represents 0.26% of the portfolio and ranks #35 among its holdings.

31 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Trails Edge Capital Partners held 282,004 shares of ImageneBio Inc worth $1.66M as of Q2 2026.
  • ImageneBio Inc was a new Trails Edge Capital Partners position in Q2 2026.
  • ImageneBio Inc made up 0.26% of Trails Edge Capital Partners's portfolio in Q2 2026, its #35 holding.
  • 31 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Trails Edge Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.